Pfm Health Sciences, LP Axsome Therapeutics, Inc. Transaction History
Pfm Health Sciences, LP
- $1.25 Billion
- Q1 2025
A detailed history of Pfm Health Sciences, LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Pfm Health Sciences, LP holds 556,545 shares of AXSM stock, worth $59.7 Million. This represents 5.2% of its overall portfolio holdings.
Number of Shares
556,545
Previous 467,427
19.07%
Holding current value
$59.7 Million
Previous $39.5 Million
64.13%
% of portfolio
5.2%
Previous 2.58%
Shares
8 transactions
Others Institutions Holding AXSM
# of Institutions
403Shares Held
36.3MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$416 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$354 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$313 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$181 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$105 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.6B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...